Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Watts

Showing results (601-610 of 610) with videos related to

Pageof 61
Sort By:
You have reached the last page of results.This site can display upto 610 results.
Neurology|December 28, 2006
Herbicide exposure modifies GSTP1 haplotype association to Parkinson onset age: the GenePD StudyJ B Wilk, J E Tobin, O Suchowersky, et al.
International Journal of Cancer|October 23, 2025
Pre-diagnostic immunological markers of bacterial translocation and liver cancer risk: A nested case-control analysis of 12 prospective cohortsCody Z Watling, Peter T Campbell, Barry I Graubard, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|July 24, 2008
Huntington CAG repeat size does not modify onset age in familial Parkinson's disease: the GenePD studyChristopher F McNicoll, Jeanne C Latourelle, Marcy E MacDonald, et al.
European Urology|August 6, 2018
Low Free Testosterone and Prostate Cancer Risk: A Collaborative Analysis of 20 Prospective StudiesEleanor L Watts, Paul N Appleby, Aurora Perez-Cornago, et al.
BMC Medicine|November 7, 2008
The Gly2019Ser mutation in LRRK2 is not fully penetrant in familial Parkinson's disease: the GenePD studyJeanne C Latourelle, Mei Sun, Mark F Lew, et al.
Plos One|December 28, 2017
Circulating sex hormones in relation to anthropometric, sociodemographic and behavioural factors in an international dataset of 12,300 menEleanor L Watts, Paul N Appleby, Demetrius Albanes, et al.
International Journal of Cancer|May 17, 2022
Circulating free testosterone and risk of aggressive prostate cancer: Prospective and Mendelian randomisation analyses in international consortiaEleanor L Watts, Aurora Perez-Cornago, Georgina K Fensom, et al.
International Journal of Epidemiology|June 21, 2022
Circulating insulin-like growth factors and risks of overall, aggressive and early-onset prostate cancer: a collaborative analysis of 20 prospective studies and Mendelian randomization analysisEleanor L Watts, Aurora Perez-Cornago, Georgina K Fensom, et al.
International Journal of Cancer|March 16, 2019
The associations of anthropometric, behavioural and sociodemographic factors with circulating concentrations of IGF-I, IGF-II, IGFBP-1, IGFBP-2 and IGFBP-3 in a pooled analysis of 16,024 men from 22 studiesEleanor L Watts, Aurora Perez-Cornago, Paul N Appleby, et al.
JAMA Neurology|March 26, 2014
A randomized clinical trial of high-dosage coenzyme Q10 in early Parkinson disease: no evidence of benefit, M Flint Beal, David Oakes, et al.
Pageof 61

Showing results (601-610 of 610) with videos related to

Sort By:
Pageof 61
You have reached the last page of results.This site can display upto 610 results.
Neurology|December 28, 2006
Herbicide exposure modifies GSTP1 haplotype association to Parkinson onset age: the GenePD StudyJ B Wilk, J E Tobin, O Suchowersky, et al.
International Journal of Cancer|October 23, 2025
Pre-diagnostic immunological markers of bacterial translocation and liver cancer risk: A nested case-control analysis of 12 prospective cohortsCody Z Watling, Peter T Campbell, Barry I Graubard, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|July 24, 2008
Huntington CAG repeat size does not modify onset age in familial Parkinson's disease: the GenePD studyChristopher F McNicoll, Jeanne C Latourelle, Marcy E MacDonald, et al.
European Urology|August 6, 2018
Low Free Testosterone and Prostate Cancer Risk: A Collaborative Analysis of 20 Prospective StudiesEleanor L Watts, Paul N Appleby, Aurora Perez-Cornago, et al.
BMC Medicine|November 7, 2008
The Gly2019Ser mutation in LRRK2 is not fully penetrant in familial Parkinson's disease: the GenePD studyJeanne C Latourelle, Mei Sun, Mark F Lew, et al.
Plos One|December 28, 2017
Circulating sex hormones in relation to anthropometric, sociodemographic and behavioural factors in an international dataset of 12,300 menEleanor L Watts, Paul N Appleby, Demetrius Albanes, et al.
International Journal of Cancer|May 17, 2022
Circulating free testosterone and risk of aggressive prostate cancer: Prospective and Mendelian randomisation analyses in international consortiaEleanor L Watts, Aurora Perez-Cornago, Georgina K Fensom, et al.
International Journal of Epidemiology|June 21, 2022
Circulating insulin-like growth factors and risks of overall, aggressive and early-onset prostate cancer: a collaborative analysis of 20 prospective studies and Mendelian randomization analysisEleanor L Watts, Aurora Perez-Cornago, Georgina K Fensom, et al.
International Journal of Cancer|March 16, 2019
The associations of anthropometric, behavioural and sociodemographic factors with circulating concentrations of IGF-I, IGF-II, IGFBP-1, IGFBP-2 and IGFBP-3 in a pooled analysis of 16,024 men from 22 studiesEleanor L Watts, Aurora Perez-Cornago, Paul N Appleby, et al.
JAMA Neurology|March 26, 2014
A randomized clinical trial of high-dosage coenzyme Q10 in early Parkinson disease: no evidence of benefit, M Flint Beal, David Oakes, et al.
Pageof 61